Inhibitory effects of phosphodiesterase 5 inhibitor, tadalafil, on mechanosensitive bladder afferent nerve activities of the rat, and on acrolein-induced hyperactivity of these nerves

BJU International

Volumn 110, Issue 6B, 2012, Pages

  Minagawa, Tomonori ^a   Aizawa, Naoki ^b   Igawa, Yasuhiko ^b   Wyndaele, Jean Jacques ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

afferent nerves; phosphodiesterase type 5; rats; urinary bladder

Indexed keywords

ACROLEIN; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER DISTENSION; BLADDER FILLING; BLADDER INNERVATION; BLADDER PRESSURE; CONTROLLED STUDY; DELTA NERVE FIBER; DOSE RESPONSE; DRUG DOSE COMPARISON; ELECTROSTIMULATION; FEMALE; NERVE CONDUCTION; NERVE STIMULATION; NONHUMAN; PELVIC NERVE; PRIORITY JOURNAL; RAT; SENSORY NERVE;

ACROLEIN; ANIMALS; CARBOLINES; FEMALE; NEURONS, AFFERENT; PHOSPHODIESTERASE 5 INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER;

EID: 84865511771     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11255.x     Document Type: Article

References (29)

1. Rosen R, Altwein J, Boyle P, et al,. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-49 (Pubitemid 37542920)
2. McVary KT,. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005; 47: 838-45 (Pubitemid 40745354)
3. Chapple CR, Wein AJ, Abrams P, et al,. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol 2008; 54: 563-9
4. McConnell JD, Roehrborn CG, Bautista OM, et al,. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-98 (Pubitemid 37542987)
5. Francis SH, Blount MA, Corbin JD,. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol Rev 2011; 91: 651-90
6. Andersson KE, de Groat WC, McVary KT, et al,. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011; 30: 292-3017
7. McVary KT, Roehrborn CG, Kaminetsky JC, et al,. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007; 177: 1401-7 (Pubitemid 46435965)
8. Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L,. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 2008; 180: 1228-34
9. McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G,. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007; 177: 1071-7 (Pubitemid 46216352)
10. Caremel R, Oger-Roussel S, Behr-Roussel D, Grise P, Giuliano FA,. Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 2010; 58: 616-25
11. Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menetrey D,. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 1995; 105: 220-32
12. Ahluwalia A, Maggi CA, Santicioli P, Lecci A, Giuliani S,. Characterization of the capsaicin-sensitive component of cyclophosphamide- induced inflammation in the rat urinary bladder. Br J Pharmacol 1994; 111: 1017-22 (Pubitemid 24148764)
13. Vizzard MA, Erdman SL, de Groat WC,. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 1996; 370: 191-202 (Pubitemid 26227145)
14. Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ,. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment. Eur Urol 2010; 59: 264-71
15. Sengupta JN, Gebhart GF,. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 1994; 72: 2420-30 (Pubitemid 24362634)
16. De Wachter S, Wyndaele JJ,. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 2003; 169: 1892-5 (Pubitemid 36443540)
17. Aizawa N, Wyndaele JJ, Homma Y, Igawa Y,. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Neurourol Urodyn 2012; 31: 148-55
18. Lavelle J, Meyers S, Ramage R, et al,. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol 2002; 283: F242-53 (Pubitemid 34778986)
19. Behr-Roussel D, Oger S, Caisey S, et al,. Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats. Eur Urol 2011; 59: 272-9
20. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA,. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 2003; 93: 280-91 (Pubitemid 37048240)
21. Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P,. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 2006; 49: 740-5 (Pubitemid 43374744)
22. Filippi S, Morelli A, Sandner P, et al,. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 2007; 148: 1019-29
23. Werkstrom V, Svensson A, Andersson KE, Hedlund P,. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int 2006; 98: 414-23
24. Yoshimura N, Seki S, de Groat WC,. Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 2001; 86: 304-11 (Pubitemid 32623235)
25. Matsumoto S, Hanai T, Uemura H, Levin RM,. Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model. BJU Int 2009; 103: 987-90
26. Streng T, Axelsson HE, Hedlund P, et al,. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 2008; 53: 391-9
27. Bautista DM, Jordt SE, Nikai T, et al,. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006; 124: 1269-82
28. Dang K, Bielefeldt K, Gebhart GF,. Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons, and capsaicin. J Neurosci 2005; 25: 3973-84 (Pubitemid 40570430)
29. Shea VK, Cai R, Crepps B, Mason JL, Perl ER,. Sensory fibers of the pelvic nerve innervating the Rat's urinary bladder. J Neurophysiol 2000; 84: 1924-33